跳至主要内容
临床试验/CTRI/2023/02/049817
CTRI/2023/02/049817已完成2 期

A prospective, randomized, open label, comparative study to evaluate the safety and efficacy of Gotu Kola with Apple formulation for its efficacy in improving immunity, anti-oxidant levels and overall improvement in general wellbeing in subjects with bacterial infection.

JAGDALE INDUSTRIES PVT. LTD0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Volunteer aged between 18 to 60 years (both inclusive)
  • 2. Subjects with Upper Respiratory Tract Infection (URTI)

排除标准

  • 1. Patients with pre-existing severe systemic disease necessitating long-term medication
  • 2. Evidence of significant uncontrolled co-morbid disease which in the investigators opinion would jeopardize patient participation.
  • 3. Any oncology, neurological (congenital or acquired), vascular or systemic disorder which could affect any of the efficacy assessments.
  • 4. Participation in the current or previous treatment with any approved or investigational health supplement(s) during the past 1 month.

研究者

相似试验